Live News REGULATION ARTICLE M impact Sep 22, 2026, 08:55 PM UTC

TriSalus Life Sciences secures FDA 510(k) clearance for device

TriSalus Life Sciences said it received FDA 510(k) clearance for a new pressure-enabled drug delivery device; TLSI shares surged 26% to $6.21 after Tuesday’s close.

TLSI

SquawkNews Newsroom 1 updates Updated Sep 22, 2026, 09:24 PM UTC

Story updates

09:24:50 PM UTC

SquawkNews

TriSalus Life Sciences Inc NASDAQ:TLSI

TriSalus Life Sciences said it received Food and Drug Administration 510(k) clearance for a new pressure-enabled drug delivery device. 21 on the news after Tuesday's closing bell. 93 and is down 29% this year.